Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

NCT06712628 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06712628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06712628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
November 7, 2024
Completion date
December 31, 2028
Enrollment
678 (estimated)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe rheumatoid arthritis